InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
57,063.20
(
-2.12%
)
Post# of 426495
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DAR53

Send PM Follow Ignore
Followers 12
Posts 940
Boards Moderated 0
Alias Born 04/07/2019

DAR53

Re: None

Wednesday, 08/23/2023 6:48:55 AM

Wednesday, August 23, 2023 6:48:55 AM

Post# of 426495
I'm looking for any response to the following real situation. A young man 36 years of age has cancer/s. One, (I don't recall the name) is a very rare cancer and is being treated through chemo (oral Votrient). The other issue is that he has tumors in his back that has to be treated by radiation. Situation declining and recently started a unique vitamin/medicine regimen (not FDA approved) but has shown some progress in various cancer patients. This drug is fenbendazole and is used by veternarians as a dewormer. The overall prospect is not good but I wanted to see what the thoughts of people on this board as to how much Vascepa might help with the inflammation and overall benefit. I'm sure it would help.
Let me know your thoughts on this. TIA.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News
InvestorsHub NewsWire

Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM

Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM

EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM

BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM

NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

Start posting your company's news
Only $200 per official company press release!